mogamulizumab

AssetAlso Poteligeo, AMG-761, KM-8761, KW-0761

Binds CCR4 on malignant T cells and induces antibody-dependent cellular cytotoxicity.

Stage
Stage not known
Modality
Antibody
Target
CCR4
0
Indications
0
Trials
1
Developer

Indications

0

    In the full profile

    • Targets and what it contains1
    • Owner and partners1
    • Evidence for its targets1
    • Signals1

    Every asset’s record: target, stage, trials and the evidence behind it.

    See Pro

    Assets